Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for nonoxynol root_version in Record Version (approximate match)

Showing 7431 - 7440 of 8631 results

First page
Previous page
Next page
Next page

ETBX-071

68TF9SDE9N

Status:

Other

Class:

CONCEPT

SPIKE GLYCOPROTEIN (SARS-COV-2) (336-350)

FN55K29HD1

Status:

Other

Class:

CONCEPT

INFLUENZA B VIRUS B/WASHINGTON/02/2019 RECOMBINANT HEMAGGLUTININ ANTIGEN

L7ZT1J7AEZ

Status:

Other

Class:

CONCEPT

RECOMBINANT RSV GLYCOPROTEIN F ANTIGEN (RSVPREFF'F')

YPS4Z8479A

Status:

Other

Class:

CONCEPT

PF-06425090 COMPONENT CLOSTRIDIUM DIFFICILE TOXOID A

TX0H4QFR5C

Status:

Other

Class:

CONCEPT

BRU-2248

WVY3K7O4NY

Status:

Other

Class:

CONCEPT

PVM/MA Decadiene crosspolymer (58000 mPa.s)

NB4LU5VBF7

Status:

Possibly Marketed Outside US

Source:

M016

(2024)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=21490045-d47b-a6e0-e063-6294a90a36f5

First approved in 2024

Source:

M016

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=21490045-d47b-a6e0-e063-6294a90a36f5

Class:

CONCEPT

Recombinant stabilized RSV B prefusion F antigen

34FS5XSD5Q

Status:

Possibly Marketed Outside US

Source:

BLA125769

(2023)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=be18292e-b1a2-4815-a0ed-003efaa6bea3

First approved in 2023

Source:

BLA125769

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=be18292e-b1a2-4815-a0ed-003efaa6bea3

Class:

CONCEPT

Recombinant stabilized RSV A prefusion F antigen

4PDL43Y9MR

Status:

Possibly Marketed Outside US

Source:

BLA125769

(2023)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=be18292e-b1a2-4815-a0ed-003efaa6bea3

First approved in 2023

Source:

BLA125769

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=be18292e-b1a2-4815-a0ed-003efaa6bea3

Class:

CONCEPT

MOONRISE PINK BETTA TRANSGENIC WHOLE (PIBS2019 RDNA CONSTRUCT)

122Q963C0P

Status:

Possibly Marketed Outside US

Source:

Moonrise Pink Betta by GloFish LLC

(2021)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cc4afc93-8b1c-49a7-9089-bfe56b237f65

First approved in 2021

Source:

Moonrise Pink Betta by GloFish LLC

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cc4afc93-8b1c-49a7-9089-bfe56b237f65

Class:

CONCEPT

Concept

ETBX-071

Concept

SPIKE GLYCOPROTEIN (SARS-COV-2) (336-350)

Concept

INFLUENZA B VIRUS B/WASHINGTON/02/2019 RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

RECOMBINANT RSV GLYCOPROTEIN F ANTIGEN (RSVPREFF'F')

Concept

PF-06425090 COMPONENT CLOSTRIDIUM DIFFICILE TOXOID A

Concept

BRU-2248

Concept

PVM/MA Decadiene crosspolymer (58000 mPa.s)

Concept

Recombinant stabilized RSV B prefusion F antigen

Concept

Recombinant stabilized RSV A prefusion F antigen

Concept

MOONRISE PINK BETTA TRANSGENIC WHOLE (PIBS2019 RDNA CONSTRUCT)

Showing 7431 - 7440 of 8631 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1